Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNKSR1 | Q969H4 | 14/20 | 0.66 |
| ▸ | AKT1 | P31749 | 4/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15811539 | 0.87 | CNKSR1 (0.66) | CNKSR1AKT1SMN1; SMN2ALDH1A1TP53 | |
| SCHEMBL19857077 | 0.87 | CNKSR1 (0.66) | CNKSR1AKT1SMN1; SMN2ALDH1A1TP53 | |
| SCHEMBL17213426 | 0.86 | CNKSR1 (0.65) | CNKSR1AKT1SMN1; SMN2ALDH1A1TP53 | |
| SCHEMBL19867321 | 0.85 | CNKSR1 (0.64) | CNKSR1AKT1SMN1; SMN2ALDH1A1TP53 | |
| SCHEMBL17213396 | 0.81 | CNKSR1 (0.65) | CNKSR1AKT1SMN1; SMN2ALDH1A1TP53 | |
| SCHEMBL15811552 | 0.81 | CNKSR1 (0.65) | CNKSR1AKT1SMN1; SMN2ALDH1A1TP53 | |
| SCHEMBL19857079 | 0.81 | CNKSR1 (0.65) | CNKSR1AKT1SMN1; SMN2ALDH1A1TP53 | |
| SCHEMBL19857081 | 0.81 | CNKSR1 (0.67) | CNKSR1AKT1SMN1; SMN2ALDH1A1TP53 | |
| SCHEMBL15811566 | 0.81 | CNKSR1 (0.67) | CNKSR1AKT1SMN1; SMN2ALDH1A1TP53 | |
| SCHEMBL15811527 | 0.80 | CNKSR1 (1.00) | CNKSR1AKT1SMN1; SMN2ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2931280-B1 | METHODS AND COMPOSITIONS FOR INHIBITING CNKSR1 | PHUSIS THERAPEUTICS INC (US) | 2018-02-14 | — | — | EP | disclosed |